pleural effusion/carbohydrate

Линкът е запазен в клипборда

СтатииКлинични изследванияПатенти

Изберете тип сортиране

Страница 1 от 65 резултата

[Carbohydrate antigens in pleural effusion from patients with lung cancer].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Sialosylated Lewisa (S-Lea) is an active antigen determinant of CA19-9 which is well known as a tumor maker. Sialosylated Lewisx (S-Lex) is a positional isomer of S-Lea. The positive percent of S-Lex and CA19-9 in pleural effusion from the patients with primary lung cancer was 49.1% and 40.0%,

[Diagnositic values of combined determination of carbohydrate antigen and tissue polypeptide antigen and neuron-specific enolase and carcinoembryonic antigen in the malignant pleural effusion].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND To evaluate the values of a new tumor marker carbohydrate antigen (CA242) and combined determination of CA242, tissue polypeptide antigen (TPA), neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) in the diagnosis of malignant pleural effusion associated with lung

Sarcoidosis presenting with massive pleural effusion and elevated serum and pleural fluid carbohydrate antigen-125 levels.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

A 55-year-old woman was admitted for an elevated serum carbohydrate antigen-125 (CA-125) level, and a left pleural effusion, which were detected at a routine health examination. Computed tomography of the chest was performed upon admission, revealing extensive bilateral paratracheal and mediastinal

Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

A panel of tumour markers including carcinoembryonic antigen (CEA), carbohydrate antigen (Ca)15-3, Ca125 and Ca19-9 were measured in the lysate of sediments and in the supernatants of pleural effusions of patients with benign and malignant disease. The tumour markers were also measured in the serum

Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND Midkine (MK) level has been shown to be elevated in serum of patients with nonsmall cell lung cancer (NSCLC). However, the diagnostic value of MK in pleural effusion in NSCLC has not been well validated and established. METHODS Samples of NSCLC-associated malignant pleural effusions (MPE)

[Carbohydrate antigen 19-9 (CA 19-9) in pleural effusions of malignant and benign origin].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

[Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Limited data are available for the diagnostic value, and the diagnostic sensitivity and specificity of pleural fluid periostin (pPOSTN) and serum periostin (sPOSTN) in malignant pleural effusion (MPE) caused by non-small-cell lung cancer (NSCLC).We

Diagnostic accuracy of tumor markers for malignant pleural effusion: a derivation and validation study.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

UNASSIGNED The utility of tumor markers (TMs) for differentiating malignant pleural effusion (MPE) from benign pleural effusion (BPE) has been a subject of controversy. The majority of published studies are single center designed and lack validation. We performed a derivation and validation study in

Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Reactive oxygen species modulator 1 (ROMO1) is recognized to be involved in cell proliferation and is elevated in serum of various cancer patients. However, ROMO1 had little research in distinguishing between malignant pleural effusions (MPEs) and benign pleural effusions

The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Pleural effusion is a common diagnostic problem. The analysis of serum and pleural fluid for tumour markers is widely used as a diagnostic aid in clinical practice. The aim of the present study was to determine the usefulness of simultaneous quantification of carcinoembryonic antigen (CEA) and

CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND The determination of the pleural fluid (PF) carcinoembryonic antigen (CEA) concentration has proved helpful in the differentiation between pleural effusions (PE) of malignant and benign origin. The present study was designed to prospectively compare the utility of CEA with that of a

[Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), NCC-ST-439, carbohydrate antigen 19-9 (CA 19-9), cytokeratin 19 fragment (CYFRA 21-1), sialyl Lewis X-i antigen (SLX), progastrin-releasing peptide (ProGRP), squamous cell carcinoma antigen (SCC) and neuron specific enolase (NSE) were

Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND The presence of tumour cells in pleural fluid or tissue defines an effusion as malignant. Cytology analysis of the pleural fluid has about 60% diagnostic sensitivity. Several tests have been proposed to improve diagnosis-among them, the concentrations of tumour markers in pleural fluid.

[Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

OBJECTIVE To investigate the clinical value of pleural effusion lung ProGRP, neuron specific enolase (NSE), cytokeratin fragment 19 (CYFRA21-1), carcino-embryonic antigen (CEA), carbohydrate antigen 153 (CA153), carbohydrate antigen 19 - 9 (CA19-9) in differential diagnosis and histological typing

Предишна
1
2
3
4
5
Следваща

Присъединете се към нашата
страница във facebook

Herbal & Natural Medicine

Най-пълната база данни за лечебни билки, подкрепена от науката

Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания